Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab: An Observational Health Data Sciences and Informatics Network Study.
Cindy X CaiAkihiko NishimuraMary G BowringErik WestlundDiep TranJia H NgPaul NagyMichael CookJody-Ann McLeggonScott L DuVallMichael E MathenyAsieh GolozarAnna OstropoletsEvan MintyPriya DesaiFan BuBrian ToyMichelle HribarThomas FalconerLinying ZhangLaurence Lawrence-ArcherMichael V BolandKerry GoetzNathan HallAzza ShoaibiJenna RepsAnthony G SenaClair BlacketerJoel SwerdelKenar D JhaveriEdward LeeZachary GilbertScott L ZegerDeidra C CrewsMarc A SuchardGeorge HripcsakPatrick B RyanPublished in: Ophthalmology. Retina (2024)
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.